Kwangdong Pharmaceutical Co Ltd
KRX:009290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kwangdong Pharmaceutical Co Ltd
Cash Equivalents
Kwangdong Pharmaceutical Co Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kwangdong Pharmaceutical Co Ltd
KRX:009290
|
Cash Equivalents
₩96.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
|
Yuhan Corp
KRX:000100
|
Cash Equivalents
₩348.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash Equivalents
₩307.8B
|
CAGR 3-Years
44%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash Equivalents
₩108.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash Equivalents
₩10B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-12%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Cash Equivalents
₩8.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kwangdong Pharmaceutical Co Ltd
Glance View
Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm operates its business through five segments. The Mineral Water Business segment supplies drinking spring water under Samdasoo brand. The Distribution Business segment distributes health drinks under brand names of Vita500 and Corn Silk Tea. The Pharmacy Business segment provides Chinese prescription cold medicines, hypertension medicines, cerebral apoplexy medicines and health drinks. The Hospital Business segment offers anticancer agents, blood vessel adjuvants, vitamin D injections and others. The Other segment provides products which not covered by Pharmacy, Hospital and Distribution segments.
See Also
What is Kwangdong Pharmaceutical Co Ltd's Cash Equivalents?
Cash Equivalents
96.3B
KRW
Based on the financial report for Sep 30, 2025, Kwangdong Pharmaceutical Co Ltd's Cash Equivalents amounts to 96.3B KRW.
What is Kwangdong Pharmaceutical Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
12%
Over the last year, the Cash Equivalents growth was -28%. The average annual Cash Equivalents growth rates for Kwangdong Pharmaceutical Co Ltd have been -1% over the past three years , 8% over the past five years , and 12% over the past ten years .
